HCA
LOGC

Harbor Capital Advisors’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Harbor Capital Advisors’s Portfolio LOGC Stock Details LOGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
2022
Q2 		$85K Buy
2022
Q1 		$154K Sell
2021
Q4 		$653K Buy